3 ms·

I’m surprised by this - there was an article posted earlier on today and the conclusion in the comments was that this wasn’t working very well? Is this actually

• celticninja 7y ago
  there seems to be a window of opportunity to use it early in the infection. I believe the Lancet published the study and it needs to be used in the first 10 days, however most people are only just thinking of going to the hospital at that stage of the infection. Although if this is approved for use perhaps we will see it being prescribed earlier, especially of combined with better and more widespread testing
• uberman 7y ago
  There are two studies with (potentially) conflicting results. The first study (by Gilead) claims that drug is effective. This is the story making the rounds at the moment. Gilead is coincidentally the maker of remdesivir. The second study (published in The Lancet) says basically that remdesivir is no better than a placebo and in some cases it makes things worse. This study was funded by the Chinese Gov and has a lead author out of Department of Respiratory Medicine, Capital Medical University, Beijing. As a result I'm sure the political camps will choose to embrace the message that aligns with their world view.
  • jonplackett 7y ago
    Thanks for the addition of the funding sources. Everything now makes perfect sense.